NeoGenomics raises $125M follow-on

NeoGenomics Inc. (NASDAQ:NEO) raised $125 million through the sale of 9.8 million shares at $12.75 in an follow-on underwritten by William Blair, Leerink Partners, Craig-Hallum, Stephens, First Analysis Securities, Janney Montgomery Scott and Benchmark Co. The price is a 14% discount to its Aug. 6 close of $14.87 when it proposed after market hours to raise $125 million.

The cancer genetic test company markets several tests, including next-generation sequencing cancer profiling, and develops companion diagnostics...